Key facts
- This page summarizes Caroline M. Loewy's Form 3 filing for eFFECTOR Therapeutics, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 11 Sep 2023, 19:36.
Caroline M. Loewy - 09 Sep 2023 Form 3 Insider Report for eFFECTOR Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 09 Sep 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 11 Sep 2023, 19:36:37 UTC
- Prior SEC filing
- 19 May 2023
- Next SEC filing
- 26 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Byrnes, Attorney-in-Fact for Caroline M. Loewy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Caroline M. Loewy filed Form 3 for eFFECTOR Therapeutics, Inc. on 11 Sep 2023.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EFTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,047
- Date
- 09 Sep 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.